Masaki Mori

14.5k citations
445 papers · 10.3k indexed · 2 hit papers · h-index 51
Topics
Colorectal Cancer Surgical Treatments (85 papers)Gastric Cancer Management and Outcomes (68 papers)Pancreatic and Hepatic Oncology Research (48 papers)
Journals
Journal of Clinical InvestigationJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Masaki Mori

423 papers receiving 10.2k citations

Hit Papers

CD13 is a therapeutic target in human liver cancer stem c...201020262015202020102014100200300400500

Peers

Masaki Mori
Comparison fields: 5 of 151
  • Oncology 5.7k
  • Surgery 4.0k
  • Pulmonary and Respiratory Medicine 3.1k
  • Molecular Biology 2.3k
  • Cancer Research 1.2k
Replace Tsutomu Fujii with:
Tsutomu Fujii Japan
Theodore S. Hong United States
Yoshiharu Sakai Japan
Suguru Yamada Japan
Jean‐Luc Van Laethem Belgium
Masayuki Sho Japan
Fausto Petrelli Italy
Inne H.M. Borel Rinkes Netherlands
Wolfram Trudo Knoefel Germany
Eiji Oki Japan
Masaki Mori relative to Tsutomu Fujii Japan Tsutomu Fujii's profile →
Citations per field
00.5×1.5×
Tsutomu Fujii · 1×
Citations per year

Countries citing papers authored by Masaki Mori

Since Specialization
Citations

This map shows the geographic impact of Masaki Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Mori more than expected).

Fields of papers citing papers by Masaki Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Mori. The network helps show where Masaki Mori may publish in the future.

Co-authorship network of co-authors of Masaki Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Mori. A scholar is included among the top collaborators of Masaki Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Mori. Masaki Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 3
5 5
6 11
7 4
8 6
9 12
10 4
11 4
12 27
13 11
14 17
15 6
16 9
17 6
18 32
19 6
20
Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
113

About Masaki Mori

Masaki Mori is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 445 papers that have together received 10.3k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (85 papers), Gastric Cancer Management and Outcomes (68 papers) and Pancreatic and Hepatic Oncology Research (48 papers). The work is most often cited by research in Oncology (5.7k citations), Hepatology (839 citations) and Pulmonary and Respiratory Medicine (3.1k citations). Masaki Mori has collaborated with scholars based in Japan, United States and Philippines. Frequent co-authors include Koshi Mimori, Hiroshi Inoue, Fumiaki Tanaka, Hiroaki Miyata, Mitsukazu Gotoh, Graham F. Barnard, Naotsugu Haraguchi, Yuichiro� Doki, Kenichi Sugihara and Keizō Sugimachi. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026